Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEIDA long-term comparison of Aldara versus Solaraze for actinic keratosis
2007-004884-24Phase 4Completed
- Sponsor
- Meda
- Start
- Jun 2008
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of imiquimod and diclofenac in actinic keratosis (AK) (2 arms), sponsored by Meda. Primary endpoint: Patient recurrence rate in the selected treatment area. Started Jun 2008; status: completed.
02
Drugs
imiquimoddiclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2007-004884-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004884-24.